Press release
Stargardt Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | IVERIC Bio, Alkeus, Kubota Vision, Astellas, Stargazer Pharmaceuticals, Belite Bio, ProQR Therapeutics
"Stargardt Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Stargardt Disease Therapeutics Market.
The report provides a detailed description of the Stargardt Disease drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Stargardt Disease Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Stargardt Disease Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Stargardt Disease therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Stargardt Disease treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Stargardt Disease drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Stargardt Disease treatment market.
Learn More about the Clinical and Commercial Development Activities in the Stargardt Disease Therapeutics Domain @
https://www.delveinsight.com/report-store/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Stargardt Disease Therapeutics Analysis
Currently, there is no treatment for Stargardt disease. Some ophthalmologists encourage people with Stargardt disease to wear dark glasses and hats when out in bright light to reduce the buildup of lipofuscin. Cigarette smoking and secondhand smoke should be avoided. Animal studies suggest that high-dose vitamin A may increase lipofuscin accumulation and potentially accelerate vision loss. Therefore, supplements containing more than the recommended daily allowance of vitamin A should be avoided, or taken only under a doctor's supervision.
There is a high unmet medical need as there are currently no treatments available for Stargardt disease. Hence, new treatments are needed to slow the progression of the disease and maintain acuity for longer. There are approx. 18+ key companies developing therapies for Stargardt disease. Currently, Belite Bio is leading the therapeutics market with its Stargardt disease drug candidates in the most advanced stage of clinical development.
Stargardt Disease Companies in the Therapeutics Market Include:
• IVERIC bio
• Nanoscope Therapeutics
• Alkeus Pharmaceuticals
• Kubota Vision
• Astellas Pharma
• Stargazer Pharmaceuticals, Inc.
• Belite Bio
• ProQR Therapeutics
• ReVision Therapeutics
And Many Others
Emerging and Marketed Stargardt Disease Therapies Covered in the Report Include:
• Tinlarebant: Belite Bio
• ASP7317: Astellas Pharma
• QR-1011: ProQR
And many more
Get an in-depth Assessment of the Emerging Therapies and Stargardt Disease Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Stargardt Disease Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Stargardt disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such asOral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Stargardt Disease Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Stargardt Disease Current Treatment Patterns
4. Stargardt Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Stargardt Disease Late-Stage Products (Phase-III)
7. Stargardt Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Stargardt Disease Discontinued Products
13. Stargardt Disease Product Profiles
14. Stargardt Disease Companies
15. Stargardt Disease Drugs
16. Dormant and Discontinued Products
17. Stargardt Disease Unmet Needs
18. Stargardt Disease Future Perspectives
19. Stargardt Disease Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/stargardt-disease-stgd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market
Lipodystrophy Market
https://www.delveinsight.com/report-store/lipodystrophy-market
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
Anaplastic Astrocytoma Market
https://www.delveinsight.com/report-store/anaplastic-astrocytoma-market
Singapore Healthcare Outlook
https://www.delveinsight.com/report-store/singapore-healthcare-outlook-report
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market
https://www.delveinsight.com/report-store/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-market
Chronic Idiopathic Constipation Market
https://www.delveinsight.com/report-store/chronic-idiopathic-constipation-market
Hay Fever Conjunctivitis Market
https://www.delveinsight.com/report-store/hay-fever-conjunctivitis-market
Nasopharyngeal Carcinoma Market
https://www.delveinsight.com/report-store/nasopharyngeal-carcinoma-market
Cerebral Infarction Market
https://www.delveinsight.com/report-store/cerebral-infarction-market
CART-related Neurotoxicity (NT) Market
https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market
Bronchial Hyperreactivity Market
https://www.delveinsight.com/report-store/bronchial-hyperreactivity-market
Chronic Focal Epilepsy Market
https://www.delveinsight.com/report-store/chronic-focal-epilepsy-market
Dental Lasers Market
https://www.delveinsight.com/report-store/dental-lasers-market
Down Syndrome Market
https://www.delveinsight.com/report-store/down-syndrome-market
Extracorporeal Circulation System Market
https://www.delveinsight.com/report-store/extracorporeal-circulation-system-market
Failed Back Surgery Syndrome Market
https://www.delveinsight.com/report-store/failed-back-surgery-syndrome-market
Germ Cell Tumor Market
https://www.delveinsight.com/report-store/germ-cell-tumor-market
Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market
India Healthcare Outlook
https://www.delveinsight.com/report-store/india-healthcare-outlook-report
Insulin Glargine Biosimilar
https://www.delveinsight.com/report-store/insulin-glargine-biosimilar-insight
Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market
Nasolabial Fold Market
https://www.delveinsight.com/report-store/nasolabial-fold-market
Neuroleptic Malignant Syndrome Market
https://www.delveinsight.com/report-store/neuroleptic-malignant-syndrome-market
Pachyonychia Congenita Market
https://www.delveinsight.com/report-store/pachyonychia-congenita-market
Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
Reactive Airway Disease Market
https://www.delveinsight.com/report-store/reactive-airway-disease-market
Seborrhea Market
https://www.delveinsight.com/report-store/seborrhea-market
Substance (Drug) Abuse Market
https://www.delveinsight.com/report-store/substance-drug-abuse-market
Synchronous Endometrial and Ovarian Cancer (SEOC) Market
https://www.delveinsight.com/report-store/synchronous-endometrial-and-ovarian-cancer-seoc-market
Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight
Urinary Tract Infection Devices Market
https://www.delveinsight.com/report-store/urinary-tract-infection-devices-market
Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market
Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stargardt Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | IVERIC Bio, Alkeus, Kubota Vision, Astellas, Stargazer Pharmaceuticals, Belite Bio, ProQR Therapeutics here
News-ID: 3296392 • Views: …
More Releases from DelveInsight Business Research LLP
Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 45+ Key Pharma C …
DelveInsight's, "Follicular Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Follicular Lymphoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Request a sample and discover the…
Muscle Spasticity Clinical Trial Pipeline Appears Robust With 15+ Key Pharma Com …
DelveInsight's "Muscle Spasticity Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Muscle Spasticity pipeline landscape. It covers the Muscle Spasticity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Muscle Spasticity pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates…
Brutons Tyrosine Kinase Inhibitors Clinical Trial Pipeline Appears Robust With 3 …
DelveInsight's "Brutons Tyrosine Kinase Inhibitors Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Brutons Tyrosine Kinase Inhibitors pipeline landscape. It covers the Brutons Tyrosine Kinase Inhibitors pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Brutons Tyrosine Kinase Inhibitors pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline…
Smoking Cessation Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Com …
DelveInsight's, "Smoking Cessation Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Smoking Cessation pipeline landscape. It covers the Smoking Cessation Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Smoking Cessation Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates in…
More Releases for Stargardt
Stargardt Disease Market Dynamics Indicate Upward Trajectory Through 2034, Repor …
The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products will significantly revolutionize the Stargardt Disease market dynamics.
DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United…
Stargardt Disease Market was valued at USD 120-150 million in 2024
Market Overview
The Stargardt Disease market is expanding steadily as advancements in retinal imaging, genetic testing, and gene-therapy research accelerate therapeutic development. Stargardt Disease, the most common form of inherited juvenile macular degeneration, is caused primarily by mutations in the ABCA4 gene and leads to progressive central vision loss.
The global market for Stargardt Disease diagnosis, management, and emerging therapeutics was valued at USD 120-150 million in 2024. With increasing clinical-trial activity…
Stargardt Disease Market to Witness Promising Upswing by 2034, DelveInsight Fore …
The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products will significantly revolutionize the Stargardt Disease market dynamics.
DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United…
Stargardt Disease Clinical Trials, Pipeline Insights, Treatment Drugs, and Compa …
DelveInsight's, "Stargardt Disease Pipeline Insight, 2024," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Stargardt…
Stargardt Disease Pipeline, Clinical Trials, Emerging Therapies, and FDA Approva …
DelveInsight's, "Stargardt Disease Pipeline Insight 2023" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Stargardt Disease pipeline landscape. It covers the Stargardt Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Stargardt Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Global Juvenile Degeneration (Stargardt Disease) Market Forecast to 2025
Juvenile Degeneration (Stargardt Disease) Market report describes the thorough and collective examination of the Juvenile Degeneration (Stargardt Disease) industry during the past, present and conjecture periods. All the business verticals like driving market situation, regional Juvenile Degeneration (Stargardt Disease) nearness, and improvement openings are clarified. Top players of the Juvenile Degeneration (Stargardt Disease) industry, their business strategies, and growth opportunities are covered in this report. A report is incomplete without…
